Single-incision vaginal approach to treat cystocele and vault prolapse with an anterior wall mesh anchored apically to the sacrospinous ligaments by Moore, Robert D. et al.
ORIGINAL ARTICLE
Single-incision vaginal approach to treat cystocele and vault
prolapse with an anterior wall mesh anchored apically
to the sacrospinous ligaments
Robert D. Moore & Gretchen K. Mitchell &
John R. Miklos
Received: 21 February 2011 /Accepted: 11 July 2011 /Published online: 25 August 2011
# The Author(s) 2011. This article is published with open access at Springerlink.com
Abstract
Introduction and hypothesis The safety and early efficacy
of a new technique to treat cystocele and/or concomitant
apical prolapse through a single vaginal incision with a
lightweight mesh anchored apically bilaterally to the
sacrospinous ligaments is reported.
Methods Women with anterior compartment and/or apical
prolapse ≥stage II underwent repair through a single
anterior vaginal wall incision with the Anterior Elevate
System (AES). The technique utilizes a lightweight (24 g/
m
2) type I mesh anchored to the sacrospinous ligaments via
two mesh arms with small self-fixating tips. The bladder
neck portion of the graft is anchored to the obturator
internus with similar self-fixating tips. The apical portion of
the graft is adjustable to vaginal length prior to locking in
place. Outcome measures included prolapse degree at last
follow-up visit, intra/post-operative complications, and
QOL assessments.
Results Sixty patients were implanted with average follow-
up of 13.4 months (range 3–24 months). Mean pre-op Ba
was +2.04±1.3 and C −2.7±2.9. Average blood loss was
47 cc and average hospital stay was 23 h. Sixty-two percent
of patients had concomitant sling for SUI. Mean post-op Ba
is −2.45±0.9 and C −8.3±0.9. There was no statistical
difference in pre- to post-op TVL. Objective cure rate at
current follow-up is 91.7% (≤stage 1). To date, there have
been no mesh extrusions. No patients have reported
significant buttock or leg pain. No patients have required
surgical revision for any reason.
Conclusion The AES is a minimally invasive technique to
treat anterior compartment and/or apical prolapse through a
single vaginal incision. Initial results show the procedure to
be safe and early efficacy is promising. Longer-term follow-
up is ongoing.
Keywords Cystocele.Vaginal mesh.Mesh complications.
Elevate.Sacrospinous ligament
Introduction
Pelvic organ prolapse (POP) is a significant health issue in
females worldwide [1, 2]. There are approximately 250,000
procedures annually in the USA for POP, with as many as
29% of women having to undergo repeat surgery [2].
Traditional anterior repair of cystocele or anterior compart-
ment prolapse utilizing the patient’s own tissue is a
compensatory procedure that utilizes weakened and/or
damaged tissue and has reported failure rates in the range of
40–60% [3]. Additionally, plication or colporrhaphy techni-
ques address only midline defects in the anterior compartment
and do not provide any apical support which may also
contribute to the failure rates seen with this type of repair [3].
Abdominal Y-mesh sacralcolpopexy has the highest cure
rates in the literature for vault prolapse, and the benefit of
utilizing mesh in this particular repair seems to outweigh
the risks [4]. It results in anatomic repair with minimal
tension and does not rely on the patients weakened tissue to
maintain support. With the success of apical graft use, more
recently, graft augmentation of prolapse repair has been
utilized via the vaginal route. A recent Cochrane review has
confirmed that mesh use in the anterior compartment has a
lower failure rate versus traditional repair [5, 6]. Mesh
trocar-based kits such as Perigee and Prolift were developed
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have shown cure rates in the range of 87–96% [7–9]. These
first-generation kits all required needles to be passed
through the groins and obturator space with mesh arms
subsequently pulled through this same space to attach the
body of the graft to the levator muscles. Although many
studies have shown successful cure rates when used by
experienced surgeons in the right patient population,
complications resulting from the external needle passes
such as visceral and vascular injury as well as post-
operative mesh complications have been concerning [9–
11]. Vaginal or pelvic pain from the mesh arms being too
tight, as well as issues such as rates of mesh extrusion as
high as 15%, have been reported [12–14]. Additionally, a
shortfall of most of these first-generation kits, is that they
did not offer true level I or apical support in the anterior
compartment, which may have led to apical failure.
In an attempt to both benefit from the advantages of mesh
use in the anterior compartment and also decrease some of the
associated risks seen in the first-generation kits, a new single-
incision vaginal approach was developed that utilizes a lighter
and less-dense type I polpypropylene mesh (Intepro Lite,
AMS) and eliminates all blind external needle passes. It also
obtains true level I support through an anterior approach, by
attaching the mesh, in an adjustable, tension-free matter to the
sacrospinous ligaments via a novel and very minimally
invasive fixation technique involving small self-fixating tips
attached to the apical mesh arms. The purpose of the current
study is to report the outcomes on a group of patients that
underwent this procedure for treatment of symptomatic
anerior compartment and/or apical prolapse at our specialty
urogynecology center.
Materials and methods
This study is a descriptive retrospective case series of 60
consecutive women with symptomatic stage 2 or greater
anterior compartment prolapse (cystocele) that underwent
anterior repair with mesh graft augmentation and vaginal
vault suspension through a single transvaginal incision
utilizing the Anterior Elevate by AMS (American Medical
Systems, Minnetonka, MN, USA) system over a consecu-
tive 12-month period at our center. Comprehensive pre-
operative urogynecologic exams were completed including
prolapse quantification utilizing the International Conti-
nence Society Pelvic Organ Prolapse Quantification (POP-
Q) staging system. Inclusion criteria were patients with
symptomatic anterior compartment prolapse ≥stage 2 that
received the Anterior Elevate procedure over a consecutive
12-month timeframe at our center. Exclusion criteria
included any patient that had any other vault suspension
procedure at the time of the surgery. Additional testing
included complex urodynamic testing to evaluate for the
presence of concomitant stress urinary incontinence (SUI)
(or detrusor instability) with and without the patient’s
prolapse reduced. If SUI was documented on urodynamic
testing with or without the prolapse reduced, the patient
was scheduled for a sub-urethral mesh tape sling procedure
at the time of surgery. A sling was not placed prophylac-
tically in any patient if SUI was not seen on testing.
Procedure technique
The procedure is begun with injection of a hydrodissection
solution (25 cc of 1% lidocaine with epinephrine 1:200,000
diluted in 250 cc of saline) into the anterior vaginal wall.
Typically, 40–60 cc of this solution is utilized. A 3 to 4-cm
vertical incision is then made in the anterior vaginal wall
starting at the level of the bladder neck towards the vaginal
vault or the cervix. The incision is kept as small as possible
and is NOT taken all the way to the apex of vagina. If the
uterus was in situ, it was left in place in the current trial. A
full-thickness dissection is then completed in the relatively
avascular vesico-vaginal space out to the pelvic sidewalls
and then up to the ischial spines bilaterally. Once the spine
is reached, a medial sweep with the index and/or middle
finger is completed to isolate the sacropinous ligament
(SSL). It should be noted that the retropubic space does not
need to be entered, nor does the ligament need to be
visualized. The bladder should also be dissected off of the
cervix or vaginal vault. The bladder neck arms of the graft
are placed into the obturator internus muscle at the level of
the bladder neck with their small self-fixating tips. The
separate apical arms are then placed in the SSLs bilaterally
approximately 2 cm medial to the ischial spine (Fig. 1). The
apical portion of the graft is then fed over the arms attached
Fig. 1 Apical arm of the Elevate system placed into the sacropinous
ligament 2 cm medial to the ischial spine. (Reproduced with
permission from AMS)
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free manner with an adjusting tool provided. Two 2–0 PDS
sutures are used to attach the graft in the midline to the
pericervical ring or the vaginal cuff. Once the final
adjustment is reached, the graft is locked in place with
small locking eyelets and the excess mesh cut off of the
apical arms. Minimal to no vaginal epithelium is excised
and the incision closed with a 2–0 delayed absorbable
suture in a running-locked fashion. Cystoscopy is complet-
ed, foley catheter and vaginal packing placed for 24 h.
If an incontinence procedure was completed concomi-
tantly, a separate sub-urethral incision was made and the
tension-free sling placed utilizing standard technique.
Remaining prolapse procedures were then completed as
necessary. If stable, patients were discharged home on post-
operative day 1. Vaginal estrogen cream was started 1 week
post-operatively and used every other day.
Patients were evaluated in the office at 4 weeks,
3 months, 6 months and then every 6 months thereafter.
ICS POP-Q staging was completed as well as subjective
assessment of prolapse (feeling or seeing a bulge),
incontinence and urinary urgency and frequency symptoms.
Quality of life questionnaires utilized were the Incontinence
Impact Questionnaire-Short form (IIQ-7) and the Urogen-
ital Distress Inventory-Short form (UDI-6). Objective cure
was defined if the midline anterior vaginal wall (points Aa
and Ba) was <1.0−1.0 cm inside the hymenal ring and the
apex was also less than or equal to stage I.
Results
Patient demographics are presented in Table 1.O ft h e6 0
patients, 11 (18.4%) had stage 2 prolapse, 43(71.6%) stage
3, and 6 (10%) had stage 4 on pre-operative pelvic
examination and POP-Q scoring. The mean Ba value
(±SD) was +2.04±1.3 cm outside the vaginal opening,
average C value (±SD) was −2.7±2.9. Sixteen (26.6%)
patients had previous anterior vaginal wall repairs and had
recurrent cystoceles. Seventy-seven percent of patients
had clinically significant apical prolapse. SUI was present
in 61.6% of patients and tension-free tape slings were
placed at the time of their surgeries. Twenty-six patients
(43.3%) presented with SUI and 11 (18.3%) were
discovered to have occult stress leakage with their
prolapse reduced during urodynamic testing. Concomitant
procedures at time of surgery included, 26/60 patients
( 4 3 . 3 % )w i t hp o s t e r i o rr e p a i r( 1 6w i t hm e s hg r a f t s ,1 0n o
graft used). No patient had any other vault support besides
the Anterior Elevate and no patient underwent hysterecto-
my (27% of patients had their uterus in situ) (Table 2).
Nineteen patients (31.6%) were sexually active prior to
surgery.
Average blood loss was 47 cc (range 25–125 cc) and was
deemed minimal. There were no post-operative bleeds or
hematomas and no patient had to be taken back to the O.R.
for bleeding or pain. There was one midline cystotomy
above the trigone that occurred during the dissection of the
anterior wall. This was closed in a two-layer fashion with
absorbable sutures and the mesh still placed and ureteral
patency confirmed. The average hospital stay was 23 h
(range 18 h to 2 days). Average time to void was 3.6 days
(range 1–10 days). Foley catheters were taken out on post-
operative day 1 and voiding trial attempted. If patient did
not pass the voiding trial, she was sent home with an
indwelling catheter and voiding trial re-attempted on post-
operative day 3. Twelve patients required catheterization for
more than 3 days with ten of these having sling procedure
at time of surgery. One patient who had the complication of
cystotomy had her catheter for 10 days and had no sequalae
from the injury. Four patients suffered from post-operative
urinary tract infections (UTI); however, one of these had a
history of recurrent UTIs.
Average follow-up was 13.4 months (range 3–
24 months). Only one patient has symptoms of recurrent
prolapse for a subjective cure rate of 98.4%. Objective/
anatomic cure rate was 91.7% using a definition of Ba<
Table 1 Demographics
N=60
Age (years±SD) 70.8±6.1 (range 51–81)
Parity 2.8±1.6 (range 0–8)
Previous hysterectomy N=44 (73%)
Menopausal N=59 (98.4%)
Estrogen use N=19 (31.6%)
Previous repair N=16 (26.6%)
>1 Previous repair N=5 (8.3%)
Prolapse stage
II N=11 (18.4%)
III N=43 (71.6%)
IV N=6 (10.0%)
Procedure n %
Hysterectomy 0 0
Sling
Mini-sling 33 55
TOT 2 3.3
TVT 2 3.3
Posterior repair
No graft 10 16.6
Mesh graft 16 26.6
Table 2 Concomitant
procedures
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for prolapse. Mean Ba value was −2.45±0.9, point C was
−8.3±0.9, and TVL was 9.1±0.3 cm. Mean vaginal length
did not change statistically from pre-operative values
(Table 3).
There have been no patients that reported any significant
buttock or leg pain that would be consistent with a
pudendal or obturator type of neuropathy. Three patients
suffered from post-operative levator myalgia or vaginal
pain that required short-term treatment with NSAIDS and/
or physical therapy with resolution of all patients’ pain. In
this predominantly elderly post-menopausal patient group,
31% were sexually active pre-operatively with one of these
patients reporting clinically significant dyspareunia that is
being treated with conservative measures (physical therapy)
and is improving.
Thirty-two patients (53%) complained of significant urge
symptoms pre-operatively, and 20 of these patients (62%)
had resolution of these symptoms post-operatively follow-
ing their surgery. One patient (1.6%) developed de-novo
urge symptoms post-operatively requiring treatment with
anticholinergic agents. Overall IIQ-7 and UDI-6 scores
improved significantly from baseline to follow-up (Table 4).
The UDI-6 subdomains of urge, stress, and obstructive
symptoms were also evaluated and a significant improve-
ment in each domain was also seen in the overall group
(Table 4). Patients that had a concomitant sling procedure or
that had a previous repair did not statistically differ in
improvement in these QOL indices compared to those that
did not (Tables 5 and 6). The UDI-6 subdomain scores were
also evaluated in the patients that had a concomitant sling
or not and these results can be seen in Table 6.
Three patients suffered from significant SUI post-
operatively. One had a concomitant tension-free sling
(TVT type) at time of surgery that failed and the other
two did not have a concomitant sling as they did not suffer
from SUI pre-operatively and tested negative on UDTs. The
patient that had the sling already placed is scheduled for
treatment with injectable bulking agents and the other two
are being scheduled for outpatient sling procedures.
There have been no mesh extrusions noted to date. There
were no post-operative infections of the mesh and no mesh
had to be removed secondary to infection or pain or allergic
reaction. No patients had to be taken back to the operating
room for revision of the mesh or release of any of the mesh
attachment points for pain or dyspareunia.
Discussion
The current series utilizing the Anterior Elevate system,
showed excellent anatomic results and an objective cure
rate of 92% with up to 24 months of f/u (mean f/u
13.4 months). Subjectively, only one patient complained of
symptomatic prolapse (98.4% subjective cure rate) and no
patient has had prolapse of the anterior wall outside of the
introitus. These results are consistent with other series
utilizing synthetic mesh for anterior compartment repair;
however, we believe the Anterior Elevate procedure to be
less invasive and a more simplified technique to place an
anterior wall graft. Additionally, it allows for concomitant
apical support at the time of anterior compartment repair.
Goldberg et al. showed the anterior approach to SSL to
result in anatomic restoration of the vaginal vault with cure
rates consistent with the posterior approach [15] which our
anatomic results support this as well.
The Anterior Elevate system utilizes small self-fixating
tips for attachment of the graft to the obturator internus
muscle at the level of the bladder neck and into the SSLs at
the apex (Figs. 2 and 3). The attachment of the graft to the
SSLs involves minimal dissection with placement of the
small tip into the mid-portion of the ligament. Secondary to
this, risk of nerve injury or post-operative pain pudendal
nerve type pain syndromes is minimal and this is supported
in the current trial with no patients developing a post-
operative pudendal nerve pain type syndrome and no
patient requiring any surgical intervention for post-
operative pain or dyspareunia. The elimination of lateral
mesh arms penetrating through and through the levators
also should help reduce the risk of vaginal or pelvic pain
from the arms being placed too tight and “banding” in the
vagina. This and/or mesh “bunching” seems to be the cause
of most cases of dyspareunia with the first generation
trocar-based mesh kits [12, 13, 16]. We did have three
Preoperative Postoperative P value (t test)
Mean POP-Q measurements
Point Aa (cm) +1.4±1.4 −2.4±0.8 <0.001
Point Ba (cm) +2.0±1.3 −2.5±0.9 <0.001
Point C (cm), cervix −2.7±2.9 −8.3±0.9 <0.001
Point Ap −1.1±1.3 −2.4±0.6 <0.001
Point Bp −0.9±1.6 −2.3±0.6 <0.001
Total vaginal length (cm) 9.09±0.5 9.16±0.3 0.343
Table 3 Pre-operative versus
post-operative POP-Q measure-
ments (mean)
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that required treatment; however, it was all deemed
muscular and responded to pelvic floor physical therapy
and did not need surgical intervention. This percentage is
consistent with other forms of prolapse treatment. One does
need to be careful; however, in the adjustment of the graft at
the apex as if too much tension is placed then this could
potentially cause pain that may require release.
Concerning the safety of the procedure, bleeding was
minimal in most cases with average blood loss at 47 cc. No
patients developed post-operative hematoma nor did any
require blood transfusion. One patient suffered a midline
cystotomy during the procedure; however, this was during
the dissection of the anterior wall and was not related to the
mesh or needle passes. We repaired the cystotomy with a
double-layered closure, still placed the mesh, and she
recovered without sequelae. Overall, with the elimination
of blind external needle passes the risk of intra-operative
bladder or vascular injury is reduced.
Our mesh extrusion rate in the current trial was very low,
and we attribute that to two variables: mesh quality and
surgical technique. The mesh used in the current trial
(Intepro Lite) is a type I macroporous polypropylene mesh
that is 50% less dense and lighter than the first generation
type I mesh (Intepro) used in Apogee/Perigee. In a
previously published trial from our center, we reported
mesh extrusion rate of 6.5% with the use of the Perigee
procedure for treatment of cystocele in a similar group of
patients [17], which is consistent with other reports in the
literature. Utilizing a less dense and softer mesh, results in a
smaller mesh load and, most likely, less inflammatory
response during healing which may reduce mesh extrusion
rates. Additionally, our surgical technique of utilizing a
deeper dissection plane, i.e., a full-thickness dissection
utilizing hydrodissection in a more avascular space, allows
for less bleeding during the procedure, less risk of post-
operative hematoma, and a thicker vascular flap healing
over the mesh. All of these factors may contribute to the
lower extrusion rate seen in our trial. Other lighter meshes
have also been introduced, however, have not shown this
low of extrusion rate. Prolift-M utilizes a soft polypropyl-
ene mesh that has a similar density to Intepro-Lite however
is 50% Monocryl, and therefore, 50% of the mesh is
absorbable. The thought was that this would decrease
vaginal exposure rate; however, in a recent study, Cosson et
al. reported a relatively high extrusion rate of 10.5% [18].
Sixteen patients (26.6%) had previous repairs and
would be considered higher risk for failure; however,
their cure rate was consistent with patients that had not
had prior repair and there was no difference in
complications seen in these patients either. In our
opinion, this is a group of patients that benefit the
greatest from a graft, given a previous failure using
their own tissue, and the results of these patients in our
series is very encouraging.
The current study is limited by its retrospective nature
and its medium-term follow-up. Another limitation, again
inherent to a retrospective single-center trial, is surgeon bias
in evaluating their own surgical outcomes. A limitation of
any surgical trial that also has to be considered is surgeon
experience with the particular procedure or similar proce-
dures as well as the anatomy of the dissection involved.
Table 4 Overall UDI-6 and IIQ-7 scores (Pre-operative vs. Post-operative) and UDI-6 subscales
Variable (n=58)
a Baseline mean±SD Follow-up mean±SD Follow-up vs. baseline P value (t test)
UDI-6 42.9±26.9 22.4±24.4 −20.6±30.8 <0.001
IIQ-7 31.5±25.7 15.4±23.4 −16.1±26.9 <0.001
UDI subscales
Irritative (56) 52.4±31.7 26.9±32.3 −24.4±38.5 <0.001
Stress (56) 44.6±29.8 25.4±30.4 −20.2±36.5 <0.001
Obstructive (58) 40.4±30.4 15.5±22.7 −24.1±32.9 <0.001
a58/60 patients filled out both pre- and post-operative questionnaires
Table 5 IIQ-7/UDI-6 scores in patients with previous anterior compartment repairs compared to those that did not
Previous repair IIQ-7 Pre IIQ-7 Post IIQ-7 Change UDI-6 Pre UDI Post UDI-6 Change
No=54 Mean 29.3 10.6 −18.7 27.7 13.6 −14.1
StDev 26.0 16.8 25.0 19.0 15.3 23.4
Yes=16 Mean 36.4 28.1 −8.3 43.5 25.6 −17.9
StDev 25.7 32.9 31.3 19.7 23.4 23.2
T test (between groups) 0.35 0.01 0.19 0.01 0.02 0.58
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Conclusion
In conclusion, we have found the vaginal repair of anterior/
apical wall prolapse utilizing a lightweight soft type I
anterior wall mesh placed via the Elevate system—a safe,
minimally invasive, and effective procedure for the treat-
ment of anterior wall prolapse in this subset of mostly post-
menopausal patients. We feel that the role of mesh in
vaginal repairs is in its infancy, and much study still needs
to be done to determine the ideal material to be utilized and
the optimal way to place and attach the graft vaginally and
the proper patient to utilize it in; however, it can be
expected that improvements in technology and techniques
will continue to improve outcomes. The small self-fixating
tips on the arms of the Elevate procedure that hold the mesh
in place are one of the least invasive approaches to fixate a
mesh graft in place vaginally to date. The elimination of
trocar-based, blind needle passes through the groins also
seems to decrease the risk of complications. We do
recommend further prospective studies with longer-term
follow-up to further help delineate its role in clinical
practice.
Fig. 3 Final adjustment of the graft into place. The bladder neck
portion of the graft has been fixated to the levators and the apical
portion of the graft is slid up the arms in a tension-free manner to
elevate the anterior wall and vault. (Reproduced with permission from
AMS)
Fig. 2 Close-up view of the small self-fixating tip attaching into the
ligament (Reproduced with permission from AMS)
Questionnaire (n) Pre-operative score Post-operative score Mean improvement P value
IIQ-7
Sling (37) 33.2±26.0 16.6±24.6 16.6±28.8 0.001
No sling (21) 28.1±26.0 13.6±22.1 14.5±24.3 0.013
T test(between groups) 0.48 0.65 0.72
UDI-6
Sling (38) 45.1±23.6 26.0±27.0 19.0±28.6 <0.001
No sling (22) 38.5±32.2 16.4±19.0 22.1±35.1 0.008
T test(between groups) 0.37 0.15 0.72
UDI subscales
Irritative
Sling (37) 53.2±31.4 26.8±33.5 26.6±37.6 <0.001
No sling (21) 48.4±32.9 27.3±31.1 20.6±40.8 0.031
Stress
Sling (36) 49.1±27.0 28.4±31.6 19.9±38.4 0.004
No sling (20) 36.7±33.6 20.5±28.1 20.8±33.7 0.012
Obstructive
Sling (35) 44.0±33.6 17.6±24.8 25.7±29.0 <0.001
No sling (21) 34.1±35.5 12.1±18.7 21.4±39.1 0.021
Table 6 IIQ-7/UDI-6 scores
(and UDI-6 domain scores) in
patients with and without con-
comitant sling at time of surgery
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